APA (7th ed.) Citation

Sigurjonsdottir, G., De Marchi, T., Ehinger, A., Hartman, J., Ullén, S., Leandersson, K., . . . Niméus, E. (2025). Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer. Breast Cancer Research and Treatment, 210(2), 271-284. https://doi.org/10.1007/s10549-024-07561-x

Chicago Style (17th ed.) Citation

Sigurjonsdottir, Gudbjörg, et al. "Evaluation of Alternative Prognostic Thresholds for SP142 and 22C3 Immunohistochemical PD-L1 Expression in Triple-negative Breast Cancer." Breast Cancer Research and Treatment 210, no. 2 (2025): 271-284. https://doi.org/10.1007/s10549-024-07561-x.

MLA (9th ed.) Citation

Sigurjonsdottir, Gudbjörg, et al. "Evaluation of Alternative Prognostic Thresholds for SP142 and 22C3 Immunohistochemical PD-L1 Expression in Triple-negative Breast Cancer." Breast Cancer Research and Treatment, vol. 210, no. 2, 2025, pp. 271-284, https://doi.org/10.1007/s10549-024-07561-x.